Experimental TB Vaccine Shows Safety in People with HIV on ART
Audio narration · Coming soon
The experimental M72/AS01 tuberculosis vaccine has demonstrated a favorable safety profile in people living with HIV who are receiving antiretroviral therapy. This finding, published in Open Forum Infectious Diseases, enhances the prospects for TB prevention in this vulnerable population. The results come from a systematic review of three studies.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews